FDA
-
-
-
-
-
-
-
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
-
-
-
-
-
-
-
Phio Pharmaceuticals begins commercial-scale production of PH-762
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
-
-
-
-
-
-
-
Phio Pharmaceuticals receives FDA acceptance for PH-762 toxicology study
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors
-
334,870 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


